Skip to Content

China Longyi Group International Holdings Ltd CGYG

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

China Longyi Group International Holdings Ltd is a holding company. Through its subsidiaries, it principally develops, manufactures and markets Superoxide Dismutase (SOD) products. SOD has applications in foods, drinks, skin care productions, pharmaceuticals, to combat ailments ranging from sunburn to rheumatoid arthritis. It produces and sells SOD Lifeblood which is a mixture of SOD and Enzymes as an antioxidant. The group primarily generates revenue from marketing its products in China.

Contact
8/Floor East Area, 69 Banjing Road, Century Golden Resources Business Center
Beijing, Haidian, 100089
T +86 1088452568
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2017
Fiscal Year End Dec 31, 2017
Stock Type Speculative Growth
Employees 47